Neonatal acute kidney injury: a case-based approach.
Michelle C StarrShina MenonPublished in: Pediatric nephrology (Berlin, Germany) (2021)
Neonatal acute kidney injury (AKI) is increasingly recognized as a common complication in critically ill neonates. Over the last 5-10 years, there have been significant advancements which have improved our understanding and ability to care for neonates with kidney disease. A variety of factors contribute to an increased risk of AKI in neonates, including decreased nephron mass and immature tubular function. Multiple factors complicate the diagnosis of AKI including low glomerular filtration rate at birth and challenges with serum creatinine as a marker of kidney function in newborns. AKI in neonates is often multifactorial, but the cause can be identified with careful diagnostic evaluation. The best approach to treatment in such patients may include diuretic therapies or kidney support therapy. Data for long-term outcomes are limited but suggest an increased risk of chronic kidney disease (CKD) and hypertension in these infants. We use a case-based approach throughout this review to illustrate these concepts and highlight important evidence gaps in the diagnosis and management of neonatal AKI.
Keyphrases
- acute kidney injury
- chronic kidney disease
- end stage renal disease
- low birth weight
- cardiac surgery
- preterm infants
- peritoneal dialysis
- healthcare
- blood pressure
- newly diagnosed
- preterm birth
- gestational age
- palliative care
- big data
- uric acid
- quality improvement
- electronic health record
- artificial intelligence
- patient reported outcomes
- machine learning
- endothelial cells